Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

T

The University of Texas at Dallas

Academic

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

17

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Enrolling by invitation

Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation

Autism Word Learning and Infant Directed-Speech

Examining Speech Production Errors in Stuttering Through High Definition - Transcranial Direct Current Stimulation

Earlier

Sep 30, 2026TrialTreatment of Verbal Retrieval Deficits in Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation

Sep 22, 2026TrialExploring Markers of Brain Health With EEG and TMS: A Pilot Study

Sep 17, 2026TrialBiobehavioral Mechanisms of Activity and Loss of Control Eating in Children

Sep 17, 2026TrialTargeted Plasticity Therapy for the Treatment of Post-Traumatic Stress Disorder

Sep 16, 2026TrialTreatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

3 more events

Sep 10, 2026TrialThe Role of Framing and Choice Architecture in Patients' Reactions and Electronic Health Records' Error Discovery and Reporting

Sep 3, 2026TrialClinical and Neurobehavioral Changes With GLP-1 (Glucagon-like Peptide-1) Discontinuation

Aug 21, 2026TrialMulti-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)